Powder Dissolution Method for Estimating Rotating Disk Intrinsic Dissolution Rates of Low Solubility Drugs
暂无分享,去创建一个
Alex Avdeef | A. Avdeef | Konstantin Tsinman | Oksana Tsinman | Dmytro Voloboy | Oksana Tsinman | K. Tsinman | D. Voloboy
[1] J. Wood,et al. Improved holder for intrinsic dissolution rate studies. , 1965, Journal of pharmaceutical sciences.
[2] A. Noyes,et al. The rate of solution of solid substances in their own solutions , 1897 .
[3] T. Haley. Asbestosis: A Reassessment of the Overall Problem , 1975 .
[4] R N Jashnani,et al. Validation of an improved Wood's rotating disk dissolution apparatus. , 1993, Journal of pharmaceutical sciences.
[5] C. Galli. Experimental determination of the diffusion boundary layer width of micron and submicron particles. , 2006, International journal of pharmaceutics.
[6] C. Goodman. United States Pharmacopeial Convention , 1988 .
[7] Lawrence X. Yu,et al. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. , 2004, International journal of pharmaceutics.
[8] A. W. Hixson,et al. Dependence of Reaction Velocity upon surface and Agitation , 1931 .
[9] Mitra Mosharraf,et al. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs , 1995 .
[10] G L Amidon,et al. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. , 2000, Journal of pharmaceutical sciences.
[11] A. Serajuddin,et al. Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. I: Phenazopyridine. , 1985, Journal of pharmaceutical sciences.
[12] General class of multiparticulate dissolution models. , 1977, Journal of pharmaceutical sciences.
[13] Alex Avdeef,et al. Absorption and drug development , 2003 .
[14] A. Avdeef. Solubility of sparingly-soluble ionizable drugs. , 2007, Advanced drug delivery reviews.
[15] Kevin C. Johnson,et al. Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.
[16] J. Carstensen,et al. Advanced Pharmaceutical Solids , 2000 .
[17] Na Sun,et al. Miniaturization of Powder Dissolution Measurement and Estimation of Particle Size , 2009, Chemistry & biodiversity.
[18] R. de Maesschalck,et al. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution. , 2005, Journal of pharmaceutical and biomedical analysis.
[19] J. Dressman,et al. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine , 2004, The Journal of pharmacy and pharmacology.
[20] Gordon L Amidon,et al. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[21] M. Adeyeye,et al. Monitoring ibuprofen release from multiparticulates: In situ fiber-optic technique versus the HPLC method: A technical note , 2007, AAPS PharmSciTech.
[22] Christos Reppas,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.
[23] Alex Avdeef,et al. Miniaturized Rotating Disk Intrinsic Dissolution Rate Measurement: Effects of Buffer Capacity in Comparisons to Traditional Wood’s Apparatus , 2008, Pharmaceutical Research.
[24] Erich Brunner,et al. Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[25] Kiyohiko Sugano,et al. Theoretical dissolution model of poly-disperse drug particles in biorelevant media. , 2008, Journal of pharmaceutical sciences.
[26] W. Higuchi,et al. Dissolution rates of finely divided drug powders. I. Effect of a distribution of particle sizes in a diffusion-controlled process. , 1963, Journal of pharmaceutical sciences.
[27] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[28] Michael Levin. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .
[29] W. Nernst,et al. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .
[30] Panos Macheras,et al. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.